The GLP is committed to full transparency. Download and review our 2019 Annual Report

Research on pain medicines seeks a genetic-trait link

| August 21, 2012

This article or excerpt is included in the GLP’s daily curated selection of ideologically diverse news, opinion and analysis of biotechnology innovation.

An international research team is launching an ambitious effort to determine whether everyday painkillers like Celebrex and Aleve could be made safer and more effective through personalized medicine, which involves tailoring treatments to patients based on genetic traits.

View the original article here: Research on Pain Medicines Seeks a Genetic-Trait Link – Wall Street Journal

News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.

Send this to a friend